www.tizianalifesciences.com
Ticker: TILS Exchange: AIM

Tiziana Life Sciences' research programme has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment, complementary to conventional treatment for mBC, and raises hopes for better survival outcomes.

Latest Reports